Top Ten Videos to watch

Spider Crash
Eric Garner Protests
Justice for Tamir sign held aloft. Stop Mass Incarcerations...
Kym Whitley
Pepsi Super Bowl 50 Halftime Show
Donald Trump's 'Crippled America' Book Press Conference
New Hampshire Primaries
TV One At The 47th NAACP Image Awards
Donald Trump Holds Rally In Biloxi, Mississippi
Behind bars
47th NAACP Image Awards Presented By TV One - Press Room
A Man Operating A Tv Camera
Maurice White
'News One Now' With Roland Martin Taping
Bill Cosby
Activists In Los Angeles Gather To Burn Likenesses Of The Confederate Flag
Flint Firebirds V Windsor Spitfires
CBC Message To America: Rep. Conyers Addresses The Damage Inflicted On Our Communities By Poverty, Mass Incarceration And Lack Of Economic Development
Iowa Caucus Ted Cruz
NewsOne Now NAACP Image Awards Preview
Student sitting at a desk in a classroom
Rahm Emanuel Announces Police Accountability Task Force As CPD Chief Is Fired
Slavery Stock image
The 16th Annual Wall Street Project Gala Fundraising Reception
Ava DuVernay
Roland Martin Blasts Stacey Dash For Comments About BET, Black Networks
President Obama Delivers State Of The Union Address At U.S. Capitol
Leave a comment

Woman holding pills close-up of hands

World — A revolution in the fight against HIV/AIDS might be around the corner, according to a new study, which found a daily pill, made of two commonly used HIV medications, lowered the risk of infection by 73 percent.

That’s for participants who took the drug almost every day. The study found a 44 percent reduction in HIV infection across all 2,499 members of the study, many of whom were taking the drug, a combination of emtricitabine and tenofovir, inconsistently.

The study, published in the New England Journal of Medicine and funded by the NIH and the Bill and Melinda Gates Foundation, is the first of its kind to show that giving people these drugs prophylactically can reduce infection risk.

This “is a significant advance in HIV prevention,” said Dr. Javier R. Lama, in a written statement. Lama is co-chair of the study protocol and based in Lima, Peru.

The study, three years in the making, looked at thousands of men and transgendered women who have sex with men across six countries. In addition to the medication, they were given safe sex counseling, condoms and care for other sexually transmitted diseases.

Similar studies are now under way for heterosexual men and women and users of injectible drugs.

Read entire article at

Share this post on Facebook! CLICK HERE:

Also On News One: